Lawsonia intracellularis subunit vaccines

Details for Australian Patent Application No. 2005206291 (hide)

Owner Intervet International B.V

Inventors Vermeij, Paul

Agent Spruson & Ferguson

Pub. Number AU-B-2005206291

PCT Pub. Number WO2005/070958

Priority 04100202.3 22.01.04 EP; 04100206.4 22.01.04 EP; 04100209.8 22.01.04 EP; 04100211.4 22.01.04 EP; 04100204.9 22.01.04 EP; 04100208.0 22.01.04 EP; 04100205.6 22.01.04 EP; 04100203.1 22.01.04 EP; 04100210.6 22.01.04 EP

Filing date 18 January 2005

Wipo publication date 4 August 2005

Acceptance publication date 3 June 2010

International Classifications

A61K 39/00 (2006.01) Medicinal preparations containing antigens or antibodies

C07K 14/195 (2006.01) Peptides having more than 20 amino acids - from bacteria

Event Publications

17 August 2006 PCT application entered the National Phase

  PCT publication WO2005/070958 Priority application(s): WO2005/070958

3 June 2010 Application Accepted

  Published as AU-B-2005206291

30 September 2010 Standard Patent Sealed

11 August 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005206292-Chimpanzee adenovirus vaccine carriers

2005206290-Thiazole derivatives as A2b antagonists